Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure supports the design of selective enzyme inhibitors and receptor modulators. Commonly employed in medicinal chemistry for constructing peptidomimetics and small molecule therapeutics due to the stability and conformational restraint provided by the cyclobutyl ring. Also utilized in the preparation of prodrugs where controlled release of the active amine is required.